<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Moderna Inc (NASDAQ:MRNA) shares traded higher by 2% on Tuesday after U.S. Food and Drug Administration scientists opted not to take a stance on the company’s COVID-19 vaccine booster shot. What Happened: In a new 45-page document, the FDA said data suggests two doses of the Moderna COVID-19 vaccine are enough to protect against the virus.
...read full article on Benzinga
